Neuphoria Therapeutics, Inc. (NEUP)
3.92
+0.03
(+0.77%)
USD |
NASDAQ |
Dec 19, 13:37
Neuphoria Therapeutics Total Assets (Quarterly): 27.34M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Adverum Biotechnologies, Inc. | 72.40M |
| Aditxt, Inc. | 11.80M |
| Recursion Pharmaceuticals, Inc. | 1.400B |
| X4 Pharmaceuticals, Inc. | 163.56M |
| Inhibrx Biosciences, Inc. | 177.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.83M |
| Shareholders Equity (Quarterly) | 12.51M |
| Debt to Equity Ratio | 0.0094 |
| Current Ratio | 2.723 |
| Net Debt Paydown Yield | -0.11% |